ROBERT NELSEN - 08 Jun 2023 Form 4 Insider Report for Sana Biotechnology, Inc. (SANA)

Role
Director, 10%+ Owner
Signature
/s/ Bernard J. Cassidy, Attorney-in-Fact for Robert Nelsen
Issuer symbol
SANA
Transactions as of
08 Jun 2023
Net transactions value
$0
Form type
4
Filing time
12 Jun 2023, 17:42:33 UTC
Previous filing
24 May 2023
Next filing
16 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SANA Stock Option (Right to Buy) Award $0 +65,000 $0.000000 65,000 08 Jun 2023 Common Stock 65,000 $6.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable as to 100% of the underlying shares on the earlier of (i) June 8, 2024 and (ii) immediately prior to Sana Biotechnology, Inc.'s next annual meeting of stockholders following June 8, 2023.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney